Should you buy this stock after it skyrocketed 33%?

What a difference one day can make. Until August 8, shares of Doximity (NYSE: DOCS)a healthcare-focused networking platform, have been in the red for the year. However, as of August 9, the company’s shares rose more than 33%, making the…